Peri-operative Vitamin D Therapy for Hepatectomy
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Safety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2)
- Status
- WITHDRAWN
- Phase
- NA
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Nutritional Indices on the Prognosis of HCC Patients
- Status
- COMPLETED
- Phase
- N/A
Lipiodol-TACE With Idarubicin Based On a Specific Emulsion Ratio for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients
- Status
- RECRUITING
- Phase
- NA
Applying Artificial Intelligence to Optimize Early-stage Hepatocellular Carcinoma Treatment Based on Multi-modal Image
- Status
- RECRUITING
- Phase
- N/A
Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
- Status
- COMPLETED
- Phase
- PHASE2
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
- Status
- RECRUITING
- Phase
- N/A
Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
- Status
- RECRUITING
- Phase
- PHASE2
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
I-FIGS Feasibility Study
- Status
- COMPLETED
- Phase
- NA
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3